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ABSTRACT (247 words) 
 
Objectives: To evaluate, among the elderly, the association of self-rated health (SRH) with 
mortality, and to identify determinants of self-rating health as “at-least-good”.   
Study Design: Individual data on SRH and important covariates were obtained for 424,791 
European and Unites States residents, >60 years at recruitment (1982-2008) in eight 
prospective studies of the Consortium on Health and Ageing: Network of Cohorts in Europe 
and the United States (CHANCES).   In each study, adjusted mortality ratios (HRs) in relation 
to SRH were calculated and subsequently combined with random-effect meta-analyses. 
Main outcome measures: All cause, cardiovascular and cancer mortality 
Results: Within 12.5 years median follow-up, 93,014 (22%) deaths occurred.  SRH “fair” or 
“poor” vs. “at-least-good” was associated with increased mortality: HRs 1.46 (95% CI 1·23-
1.74) and 2.31 (1.79-2.99), respectively.  These associations were evident: for cardiovascular 
and, to a lesser extent, cancer mortality, and, within-study, within-subgroup analyses.  
Accounting for lifestyle, sociodemographic, somatometric factors and, subsequently, for 
medical history explained only a modest amount of the unadjusted associations.  Factors 
associated with favourably SRH were: sex (males), age (younger-old), education (high), 
marital status (married/cohabiting), physical activity (active), body mass index (non-obese), 
alcohol consumption (low-to-moderate) and previous morbidity (absence).   
Conclusion 
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SRH provides a quick and simple tool for assessing health and identifying groups of elders at 
risk of early mortality that may be useful also in clinical settings. Modifying determinants of 
favourably rating health, e.g. by increasing physical activity and/or by eliminating obesity 
may be important for older adults to “feel healthy” and “be healthy”. 
Keywords: self-rated health; all-cause mortality; elderly; ageing; CHANCES; cohort 
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Abbreviations.  
CHANCES: Consortium on Health and Ageing: Network of Cohorts in Europe and the 
United States;  
CI: Confidence Interval;  
HR: Hazard Ratio;  
OR: Odds Ratio;  
SRH: Self-Rated Health;  
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1. INTRODUCTION 
Self-rated health (SRH) has been used as a health indicator since the early 50s by sociologists 
in health research [1]. SRH is assessed through a single-item question enquiring about a 
person’s health with responses ranging from “excellent/very good” to “poor/very poor” [2-4]. 
Despite differences across these scales, it has been shown that they provide concordant 
answers [5]. 
SRH was firstly used by epidemiologists in the 80s, as a simple, convenient tool to assess 
health of older individuals [6]. Since then, the association of SRH with mortality has been 
documented by studies in Western and Asian populations of elders [7-12]. In 2006, a meta-
analysis of 22 studies estimated 2-fold higher mortality risk associated with poorer SRH [13]. 
Several explanations have been proposed for the consistently-shown association of SRH with 
mortality. It has been argued that SRH among older individuals may reflect gender, education, 
lifestyle and cultural differences [12].  Nevertheless, studies focusing on subgroups defined 
by sex [14-18], or education [18-24], showed inconsistent results.  Moreover, it has been 
hypothesized that SRH may be a proxy marker of “true” health [25-27]. SHR, however, 
remains a predictor of mortality even after controlling for objective assessment of health 
status [7, 13]. Finally,  it has been stated that the association of SRH with all-cause mortality 
may reflect mortality from chronic diseases with greater impact of daily life, as opposed to 
mortality due to aggressive diseases with shorter time-to-death intervals; relevant studies are, 
however, limited [12].   
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Using centrally harmonized data from eight prospective single- and multi-centre cohort 
studies participating in the Consortium on Health and Ageing: Network of Cohorts in Europe 
and the United States (CHANCES), we sought to address the above-indicated issues by 
evaluating: a) the association of SRH with all-cause, cardiovascular and cancer mortality in 
older residents of Europe and US, b) the relative merit in the indicated associations of 
controlling for potential confounders including medical history and, c) common patterns of 
sociodemographic, lifestyle, somatometric and medical history characteristics that determine 
the perception of older people’s health in this multi-region population.  To our knowledge this 
is the first, prospective investigation of that size that has investigated simultaneously the 
above-mentioned research questions.    
2. METHODS 
2.1 Participants 
Details on CHANCES (http://www.chancesfp7.eu) have been published [28]. Overall, 
CHANCES includes fourteen single- or multi-centre on-going prospective cohort studies, 
undertaken in twenty three European and three non-European countries including the United 
States.  Data collected within each study were harmonised according to pre-agreed 
harmonisation rules [29]. In total, 683,228 older adults, defined in most cohorts as being >60 
years at recruitment, are included in CHANCES.   
 For each study, investigators satisfied the local requirements for ethical research, and 
obtained informed consent from participants. 
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2.2 Assessment of SRH  
SRH at recruitment was assessed in eight of the 14 CHANCES studies. Details are shown in 
supplementary Table 1.  
In each study, the question: “In general how would you rate your health over the last year” 
(Global SRH) was self-administered at recruitment.  In SHARE the question “how would you 
rate your health in general” was used instead. Answers across studies were categorised in 
three groups as follows: “Poor” (including also “very poor”); “Fair”; and  “at-least-good” 
(including “Good”, “Very good” and “excellent”).   
2.3 Assessment of lifestyle, anthropometry and medical history  
At enrolment, sociodemographic, lifestyle and medical history data were recorded (and 
subsequently harmonized) in most cohorts and anthropometric measures were undertaken.  
Physical activity was not assessed in EPIC-Elderly Umea and MORGAM. History of cancer 
was not available for this analysis in MORGAM.  
2.4 Follow-up and death ascertainment  
Vital status and cause of death were ascertained through record linkage with official death 
registries or through active follow-up (death certificates). In SHARE, date and cause of death 
were obtained from an “end of life interview” with contact persons. Cause-specific mortality, 
defined as the underlying cause of death was classified as “definite” and “possible” (29). 
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Primary outcome was all-cause mortality. Secondary outcomes were cardiovascular (CVD) 
and cancer mortality (“definite”/possible” combined).   
From the initial 462,401, individuals, ≥ 60 years at enrolment, 37,610 were excluded due to 
missing/unreliable information about vital status or SRH.  Eventually, 424,791 participants 
(93,014 deaths) were included in this study.   
 
2.5 Statistical analyses 
2.5.1 By participating study. The SRH-mortality associations were estimated through Cox 
regression models stratified by recruitment age (in age intervals) and cohort of recruitment (in 
multi-cohort studies). The underlying time scale was age at exit, (age of death or age at last 
follow-up for participants who were alive or lost from follow-up at last contact (censored)). 
Age at enrolment was the entry time.  
Potential confounders were: sex, physical activity (vigorous physical activity/week,  
categorically: inactive: 0 hours; active: >0 hours; unknown), current smoking (categorically: 
non-smoker; daily; unknown), ethanol intake (g/day) at recruitment (categorically: sex-
specific tertiles; unknown), body mass index (categorically: <25 kg/m2; >25 to <30 kg/m2 ; 
>30 kg/m2; unknown),  education (categorically: no formal/primary school; 
technical/secondary school; college/university/longer; unknown), and marital status 
(categorically: married/cohabiting; single/divorced/separated; widowed; unknown). Medical 
history at recruitment was considered through indicators (yes/no) of confirmed/self-reported 
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diagnosis of major morbidities: coronary heart disease (CHD), stroke, type 2 diabetes (T2D) 
mellitus, or cancer. A morbidity score indicating the number of these conditions (0-4) was 
also created.  
We evaluated the relative merit of the previously-indicated potential confounders in the SRH-
mortality association by fitting: MODEL 1: stratifying for age at recruitment, adjusting for 
sex; MODEL 2: MODEL 1 plus all indicated factors except medical history, and, MODEL 3: 
MODEL 2 plus the four indicators of medical history.  The SRH-mortality association was 
evaluated also in subgroups by: sex; age: (<70yrs; >70yrs), and; educational attainment: 
(<primary school; >primary but <college; >college).  In order to address whether the 
association of SRH with mortality differentiates across different levels of prevalent morbidity, 
we also evaluated the indicated association among those with no, 1 of >2 prevalent health 
conditions. The same models were fitted for CVD and cancer mortality among participants 
without CHD, stroke, T2D or cancer at recruitment. The focal event was CVD or cancer 
death, respectively, and death from other causes was censored.  
Determinants of SRH were evaluated by considering SRH as binary outcome (“at-least-good” 
vs. “fair-or-worse”) in logistic regression models including all indicated factors, overall, and 
in subgroups by morbidity score and sex.  
2.5.2 Overall studies. From the eight studies, six shared individual data from selected sub-
cohorts which were analysed centrally (Supplementary Table 1).  HAPIEE and SENECA 
analysed their data locally using a common programming code. Meta-analyses were 
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subsequently performed to calculate overall pooled estimates of study-specific HRs/ORs, 
using random effects models [30] to account for any statistical between-study heterogeneity 
[31]. Sensitivity/subgroup analyses were undertaken to further explore heterogeneity (see 
Results).  
Analyses were performed using STATA (Stata Corporation: Stata statistical software, release 
11).   
 
3. RESULTS 
Mean follow-up ranged from 4.6 (SENECA) to 17.8 years (MORGAM).  Based on a total of 
4,615,162 person-years of observation, 93,014 deaths were observed among the 175,121 
women and 249,670 men of the 8 participating studies. Number of participants/deaths, 
percentage of individuals > 70 years at recruitment, person-years of follow up and crude 
mortality rates are shown in Table 1, by study, sex and SRH. The majority of participants - 
135,412 (77%) women and 204,061 (82%) men - rated their health as good/very good.  
Evident in this Table are differences across cohorts with respect to number and age 
distribution of participants which are reflected in differences in mortality rates.  Nevertheless, 
in the vast majority of the studies a clear trend of increased mortality with lower SRH is 
evident, in both men and women.  
In Table 2 the distribution of the 424,791 individuals from the 8 participating studies across 
categories of sociodemographic, lifestyle and somatometric variables and SRH are shown. 
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Men and women of higher education rated their health higher and so did those who were 
physically active, with ethanol intakes in the 2nd and 3rd tertiles, and married/cohabiting (men 
only). Of note, ethanol intakes were low with median intakes (g/day): 0.18 (practically non-
consumers), 1.87 (low consumers) and 18.93 (moderate consumers) in the 1st, 2nd and 3rd 
tertiles.  SRH of older (≥65 years) and obese men and women, as well as, of smokers (men 
only) was more often “fair”/”poor” than “at-least-good”.   
The distribution of individuals across prevalent medical conditions by participating study and 
SRH is shown in supplementary Table 2.  Differences in patterns and frequency of prevalent 
conditions across studies were evident, reflecting differences in selection criteria and methods 
of assessment of the indicated conditions.  Nevertheless, a notable correlation of SRH with 
the indicated morbid conditions (increasing percentage of prevalent morbidities by decreasing 
SRH) was apparent in all cohorts. 
The study-specific, as well as, overall (using random-effects models) association of SRH with 
all-cause mortality is depicted in Figure 1 for each previously-indicated model.   HAPIEE 
included only participants with complete data in all covariates in survival analyses and, 
therefore, 423,730 participants (92,743 deaths) were analysed. Study-specific HRs indicated 
increased mortality rates for SRH “fair” vs. “at-least-good” in all models/studies with the 
exception of the relatively small MORGAM (models 2 and 3).  The overall sex-age adjusted 
HR (95% Confidence Interval (CI)) was 1.69 (1.30, 2.21), and was reduced by 5% (1.60 
(1.27, 2.01)) when additional confounders were accounted for, and by another 9% (1.46 (1.23, 
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1.74)) when medical history was also included. The corresponding HRs for the “poor” vs. “at-
least-good” comparison were all indicative of a strong, consistent association with a summary 
age-sex adjusted HR (95% CI) of 3.09 (2.11, 4.52), which was reduced to 2.73 (1.93, 3.87) in 
model 2 and to 2.31 (1.79, 2.99) in model 3.  Between-studies heterogeneity was substantial 
(I2 >90% for all estimates).   
The estimated associations between SRH and mortality (model 3) were remarkably consistent 
in sensitivity analyses: a) restricted to individuals with no missing values in any potential 
confounder, b) excluding the dominating due to its large sample size NIH-AARP study, c) 
restricted to six studies which provided individual data, and d) excluding events of the first 
two years of follow-up – this analysis was undertaken to explore the impact of potential 
misclassification in self-reported morbidity (a predictor of mortality) which was used as a 
confounder in the overall analysis.  Heterogeneity remained high and was slightly reduced 
only when NIH-AARP was excluded. 
Subgroup analyses provided very similar estimates for the SRH-mortality associations except 
for the most highly educated people among whom the associations were somehow stronger 
(Supplementary Table 3). Between-cohort heterogeneity remained generally large, except in 
subgroups defined by educational attainment (reduction up to 50% in I2 for the “poor” vs. “at-
least-good” comparison) and morbidity score (I2<1% in the (small) group with >2 prevalent 
conditions).   
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In Table 3 the associations of SRH with CVD and cancer mortality are shown, using studies 
with consistent data for individuals with no previous CHD, stroke, cancer or T2D which were 
analysed centrally.  For CVD mortality, within-study and overall estimated associations were 
very similar to those for all-cause mortality but with greater uncertainty (wider confidence 
intervals) due to the reduction of number of individuals/events.  The association with cancer 
mortality of SRH was evident only for the “poor” vs. “at-least-good” comparison in all studies 
of modest size and overall.   Excluding the dominating NIH-AARP study reduced the SRH-
CVD/cancer mortality associations and the between-study heterogeneity, but did not alter the 
statistical significance of the estimates.  
Analysis of determinants of SRH, (supplementary Table 4) revealed that men compared to 
women had 20% higher odds of rating their health as “at-least-good” rather than “fair-or-
worse”.  Excess in the corresponding odds was also observed for higher education, physical 
activity, and low-to-moderate ethanol intakes.  In contrast, being older, obese (but not 
overweight) and single/separated decreased the odds of favourably rating health. Finally, 
having at-least-one of prevalent cancer, CHD, stroke or T2D was associated with a 56% 
decrease in the odds of higher SRH.  
This pattern of determinants of SRH was generally evident a) in study-specific analyses, b) in 
subgroups by morbidity score and sex, and c) when the largest study (NIH-AARP) was 
excluded.  
4. DISCUSSION 
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In this large, pooled investigation of eight single- and multi- centre cohort studies, we found 
that SRH “fair” or “poor” compared to “at-least-good” was associated with a 1.5 and >2 fold 
increased all-cause mortality, respectively.  These associations were only slightly altered after 
adjustment for sociodemographic, somatometric and lifestyle factors and, subsequently, for 
medical history, and were consistent: a) in the vast majority of participating studies covering 
southern, northern, central and eastern European countries, as well as the US, b) in subgroups 
by sex, age, medical history and educational level, and c) for CVD and, to a lesser extent, 
cancer mortality. We also identified profiles of people who favourably rated their health, 
consisting of non-modifiable (sociodemographic) and modifiable (lifestyle) characteristics, as 
well as, medical history.  This is the first multi-region investigation of this size which 
explored simultaneously the above issues. 
Results of our study corroborate and add to existing evidence from studies in Europe, US and 
Asia regarding the apparent association of SRH with mortality [10-13, 32].  The magnitude of 
the associations estimated from our data are similar to that of the 2006 meta-analysis [13] and 
of recent studies in Western countries [10, 11], but higher than those reported in Asian 
populations- this discrepancy is probably attributed to differences in culture and attitudes 
regarding the perception and reporting of “health” [12, 18, 33, 34].  
Certain questions need to be considered in view of these results: Is SRH a proxy marker of 
“true” health among older adults, and could SRH substitute for more “objective” measures of 
health?  Is the SRH-mortality association evident only in certain subgroups, and/or, for 
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specific causes of death? Which characteristics are captured by SRH that may contribute to 
the apparent survival benefit? 
Regarding the first question, it has been shown that SRH is strongly correlated with objective 
assessment of health such as medically diagnosed conditions [26, 27]. This was also evident 
in our study regarding SRH and prevalence of serious morbidities.  Nevertheless, the 
association of SRH with mortality was only partly explained when these conditions were 
taken into account.  Although unmeasured and residual confounding cannot be ruled out, SRH 
appears to capture other dimensions of “true” health and, thus, can supplement, (but not 
substitute), important, objective health indicators when studying mortality of older adults [33, 
35-38]. 
Regarding the second question, previous studies reported conflicting results for the SRH-
mortality association within certain subgroups, or, for cause-specific mortality, partly due to 
inherent differences with respect to design, populations accrued, and assessment of variables 
of interest [12, 20-22, 39, 40]. In our study, having the advantage of using harmonized data 
for exposure/covariates, we found that the SRH-mortality association was consistent in 
subgroups defined by, sex, age, education and medical history in the majority of studies and 
overall.  Moreover, our analyses confined to apparently healthy individuals, indicated 
associations of SRH with CVD and cancer mortality – for the latter only for the “poor” (but 
not “fair”) vs. “at- least-good” SRH comparison. SRH has been associated with CVD 
mortality previously but literature is rather limited [12, 40]. Results regarding cause-specific 
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mortality, however, should be cautiously interpreted since information on date of diagnosis, 
type, severity and treatment or either diseases, should be also accounted for.  Moreover, SRH 
was only assessed at recruitment and may have changed in the light of underlying diseases, 
even before diagnosis. More research is needed towards this direction.  
To address the third question, we identified overall profiles of SRH at-least-good. We 
consistently observed that being male, younger-old, educationally advanced, married or 
cohabiting, physically active, not obese, low-to-moderate ethanol consumer, and apparently 
healthy, increases the probability among elders of favourably rating their health.  Notably, 
apart from inherent characteristics (sex and age) and non-modifiable (among older adults) 
status such as education, the rest are well-documented modifiable risk factors associated with 
life-expectancy.   
To our knowledge, the present work is the largest and most comprehensive study of the 
association of SRH with mortality of older adults. Other strengths are the multi-region 
population covered, allowing for broad generalizability of our results, the hard endpoint used, 
eliminating the role of outcome-misclassification, the harmonised data, ensuring minimal 
differences in exposures/covariates assessment/recoding, and the high statistical power, 
allowing for precise estimates and several subgroup analyses. Common analyses were 
undertaken in all studies increasing the validity of summary estimates as compared to a 
typical meta-analysis of differently-conducted published studies.  
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There is also a number of limitations. Despite central harmonization, between-study 
differences in design and definitions of original variables still exist.  Participants may not be 
representative of the corresponding general populations but this is unlikely to have biased the 
estimated associations due to the prospective design of studies included.  A related issue is the 
probability of selective mortality in these data, implying that inferences of our study may 
apply mainly to a “healthy” population of elders.  Nevertheless, our results were generally 
consistent when individuals with serious morbidities at recruitment were analysed.  We used 
only baseline SRH which may have changed during follow-up, although SRH is considered to 
remain stable even after major health events [41].  
A further limitation was the substantial between-study statistical heterogeneity which was, 
partly, due to the inclusion of larger and smaller cohorts, resulting in variation in the precision 
of the risk estimates, which may have inflated I2 values [42]. Repeating the meta-analyses 
without the dominating NIH-AARP led, generally, to lower but still high I2 values.  
Nevertheless, the relative risk estimates appear remarkably consistent in all analyses. 
In this large, prospective investigation across Europe and US, we observed increased 
mortality in people 60 years or older with poorer SRH, consistent across geographical regions, 
sex, age groups, health status and level of education. We also identified profiles of elderly 
who favourably rate their health, that include modifiable risk factors such as physical activity 
and obesity. Our results corroborate and add to existing evidence by supporting the use of 
SRH as a screening tool to identify groups of elders at higher risk of early mortality which can 
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be of value even in clinical settings. Given the current trends in demographic ageing and the 
increased morbidity and mortality among older adults, the shift in the indicated socio-lifestyle 
factors that determine SRH is important in order for older adults to “feel healthy” and “be 
healthy”.   
4.1 Conclusions 
SRH provides a quick and simple tool for assessing health and identifying groups of 
elders at risk of early mortality. Modifying determinants of favourably rating health, e.g. 
by increasing physical activity and/or by eliminating obesity may be important for older 
adults to “feel healthy” and “be healthy”. 
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Table 1. Number of Individuals and Deaths, Percentage of Elders (> 70 Years) at Recruitment (1982-2008), and Mortality Ratesa of the 424,791 Study Participants 
(93,014 Deaths), per study, sex and Self-Rated Health at Recruitment.  The Consortium on Health and Ageing: Network of Cohorts in Europe and the United States 
Participants. 
 
 Self-Rated Health  
 
 “At-least-goodb” “Fair” “Poor” 
 
 Men 
Study/Cohort >70 yrsc 
(%)   
N Deaths Yd MRa N Deaths Yd MRa N Deaths Yd MRa 
EPIC Elderly 21% 3314 746 37.342 19.98 1650 547 16.984 32.21 321 152 3.0500 49.84 
ESTHER 23% 1,834 270 16.328 16.54 721 189 6.082 31.08 61 22 0.457 48.09 
HAPIEE 0% 1,909 193 11.361 16.99 4478 754 25.672 29.37 1127 370 5.873 63.00 
MORGAM 27% 1,208 715 16.464 43.43 229 96 2.254 42.59 52 37 0.412 89.69 
NIH-AARP 6% 188,289 39,254 2177.260 18.03 26,933 12,298 264.340 46.52 4,696 3,233 34.265 94.35 
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SENECAe 100% 745 337 6.065 55.56 317 189 2.190 86.31 101 76 0.599 126.74 
SHARE 47% 5,483 442 26.358 16.77 2605 478 11.615 41.15 1089 347 4.283 81.02 
TROMSØ 43% 1,279 665 15.126 43.96 1,097 696 11.415 60.97 132 107 1.043 102.59 
  Women 
EPIC Elderly 20% 4,046 446 47.343 9.42 2699 411 29.918 13.74 700 151 7.250 20.83 
ESTHER 22% 1,979 145 18.290 7.93 878 142 7.866 18.05 41 8 0.360 22.24 
HAPIEE 0% 1,432 67 9.132 7.34 5016 361 30.110 11.99 1799 240 10.327 23.24 
MORGAM 24% 1,063 462 17.246 26.79 230 66 2.344 28.16 62 38 0.548 69.28 
NIH-AARP 6% 119,422 17602 1420.760 12.39 18,291 6,174 195.440 31.59 2,866 1,607 24.500 65.59 
SENECA 100% 628 135 5.805 23.26 404 129 3.487 37.00 154 71 1.239 57.31 
SHARE 49% 5,568 317 27.116 11.69 3261 394 15.210 25.90 1503 336 6.337 53.02 
TROMSØ 50% 1,274 502 16.59 30.26 1,630 868 19.182 45.25 175 129 1.739 74.18 
32 
 
Abbreviations: AT, Austria; BE, Belgium; CH, Switzerland; CZ, Czech Republic; DK, Denmark; EPIC, European Prospective Investigation into Cancer and nutrition; 
ESTHER, Epidemiological Study on Chances for Prevention. Early Detection. and Optimized THErapy of Chronic Diseases at Old Age; ES, Spain; FR, France; DE, 
Germany; GR, Greece; HAPIEE,  the Health. Alcohol and Psychosocial factors in Eastern Europe; IT, Italy; IL, Israel; LT, Lithuania; MORGAM, MOnica Risk. Genetics. 
Archiving and Monograph; MR, Mortality Rates; NL, Netherlands; NIH-AARP, National Institutes of Health-American Association of Retired Persons Diet and Health; PL, 
Poland; RU, Russia; SENECA, Survey Europe on Nutrition in the Elderly: a Concerted Action; SHARE, Survey of Health. Ageing and REtirement in Europe; SE, Sweden;  
 
a per 1000 person years 
b good or very good (including excellent) 
cAge at recruitment 
d Y=Person Years/1000 
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Table 2. Distributions (Numbers and Column %) of the 249,670 Men and 175,121 Women Participating in the 8 Studies, by Certain Characteristics at Enrolment 
(1982-2008), and Categories of Self-Rated Health. The Consortium on Health and Ageing: Network of Cohorts in Europe and the United States Participants. 
Characteristics at recruitment Men  Women 
 Self-Rated Health  Self-Rated Health 
 
“at–least-gooda” “Fair” “Poor” Total  “at–least-gooda” “Fair” “Poor” Total 
Age >65 yrs 116,087 23,536 4,696 144,319  74,655 19,520 4,654 98,829 
% 56.9 61.9 62.0 57.8  55.1 60.2 63.8 56.4 
Physical Activity: Activeb 108,319 13,682 1,691 123,692  59,468 9,137 1,536 70,141 
% 53.1 36.0 22.3 49.5  43.9 28.2 21.0 40.1 
Smoking status: Daily smoker 19,278 6,024 1,316 26,618  16,702 4,139 766 21,607 
% 9.4 15.8 17.4 10.7  12.3 12.8 10.5 12.3 
Ethanol consumption: >1st tertilec 135,669 18,946 2,730 157,345  85984 12,009 1,725 99,718 
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% 66.5 49.8 36.0 63.0  63.5 37.1 23.6 56.9 
Body Mass Index:  > 30 kg/m2 35,889 10,505 2,045 48,439  26460 11,839 2,944 41,243 
% 17.6 27.6 27.0 19.4  19.5 36.5 40.3 23.6 
Education: > primary education 190,386 31,786 5,923 228,095  122,177 23,794 4,654 150,625 
% 93.3 83.6 78.2 91.4  90.2 73.4 63.8 86.0 
Marital status:  married/cohabiting 176,011 31,321 6,127 213,459  60,621 14,845 3,318 78,784 
% 86.3 82.4 80.8 85.5  44.8 45.8 45.5 45.0 
TOTAL 204,061 38,030 7,579 249,670  135,412 32,409 7,300 175,121 
 
a Good or very good (including excellent) 
b >0 hours of vigorous physical activity/week; EPIC-Elderly UMEA and MORGAM do not have data available on physical activity 
c Based on sex specific ethanol intake at enrolment 
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Table 3. Fully Adjusteda HR and 95% CI of Cardiovascular and Cancer Mortality Associated with Self-
Rated Health, Overall, and by Participating Cohort.  The Consortium on Health and Ageing: Network of 
Cohorts in Europe and the United States Participants. 
Cause of death  N Deaths HRfair/“at-least-
good” 
95% CI HRpoor/“at- 
least- good” 
95% CI 
    lower upper  lower upper 
Cardiovascular         
ALLb 280,661 12,781 1.56c 1.12 2.16 2.87c 1.96 4.22 
EPIC-Elderly 10,252 746 1.24 1.06 1.45 2.33 1.83 2.96 
ESTHER 3,808 126 1.73 1.19 2.51 1.06d 0.25 4.41 
MORGAM 2,341 395 1.31 0.92 1.86 3.24 1.87 5.61 
NIH-AARP 264,260 11,514 2.03 1.93 2.15 3.82 3.36 4.35 
Cancer         
ALLb 280,661 20,787 1.26e 0.91 1.75 2.37e 1.37 4.11 
EPIC-Elderly 10,252 676 0.99 0.84 1.19 1.61 1.22 2.13 
ESTHER 3,808 175 1.23 0.88 1.72 1.31f 0.47 3.67 
MORGAM 2,341 479 1.18 0.845 1.65 3.09 1.85 5.14 
NIH-AARP 264,260 19,457 1.68 1.61 1.76 3.67 3.31 4.06 
Abbreviations: CI, Confidence Interval; EPIC, European Prospective Investigation into Cancer and nutrition; 
ESTHER, Epidemiological Study on Chances for Prevention. Early Detection. and Optimized THErapy of 
Chronic Diseases at Old Age; HAPIEE,  the Health. Alcohol and Psychosocial factors in Eastern Europe; HR, 
Hazard Ratio; MORGAM, MOnica Risk. Genetics. Archiving and Monograph; NIH-AARP, National Institutes 
of Health-American Association of Retired Persons Diet and Health; SENECA, Survey Europe on Nutrition in 
the Elderly: a Concerted Action; SHARE, Survey of Health. Ageing and REtirement in Europe;   
 
a Only individuals with no history of coronary heart disease, stroke, cancer or type 2 diabetes mellitus were 
analysed.  Adjusting by Model 3 
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b Cohorts with consistent information on cause of death and with available individual data, which were analysed centrally, 
were included (EPIC-Elderly, ESTHER MORGAM and NIH-AARP).  
c I2 for heterogeneity: HRfair/”at-least-good”: 92.1%,  HRpoor / “at-least-good”: 80.4% 
d Only 50/3,808 (1.3%) of the ESTHER individuals had self rated heath “poor”.  Only 2/50 (4%) were dead due to 
cardiovascular events 
e I2 for heterogeneity: HRfair/”at-least-good”:92.2% HRpoor / “at-least-good”:90.8% 
f Only 50/3,808 (1.3%) of the ESTHER individuals had self rated heath “poor”.  Only 4/50 (8%) were dead due to 
cancer 
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Figure 1: Meta-Analysis of the Association of Self-Rated Health, with Mortality according to Models 1, 
2 and 3.  A) HRs for the “fair” vs “at-least-good” comparison; B) HRs for the “poor” vs “at-least-good” 
comparison.  The Consortium on Health and Ageing: Network of Cohorts in Europe and the United States 
Participants. 
A) 
NOTE: Weights are from random effects analysis
.
.
.
Model 1
EPIC-Elderly
ESTHER
HAPIEE
MORGAM
NIH-AARP
SENECA
SHARE
TROMSO
Subtotal  (I-squared = 98.8%, p = 0.000)
Model 2
EPIC-Elderly
ESTHER
HAPIEE
MORGAM
NIH-AARP
SENECA
SHARE
TROMSO
Subtotal  (I-squared = 98.2%, p = 0.000)
Model 3
EPIC-Elderly
ESTHER
HAPIEE
MORGAM
NIH-AARP
SENECA
SHARE
TROMSO
Subtotal  (I-squared = 96.7%, p = 0.000)
study
CHANCES
12730
5514
15034
2844
360497
2015
19509
5587
12730
5514
15034
2844
360497
2015
19509
5587
12730
5514
15034
2844
360497
2015
19509
5587
N
2453
776
1860
1414
80168
791
2314
2967
2453
776
1860
1414
80168
791
2314
2967
2453
776
1860
1414
80168
791
2314
2967
Deaths
1.39 (1.28, 1.52)
1.92 (1.66, 2.22)
1.65 (1.30, 2.10)
1.23 (1.03, 1.48)
2.61 (2.57, 2.65)
1.75 (1.48, 2.06)
1.95 (1.77, 2.16)
1.38 (1.28, 1.49)
1.69 (1.30, 2.21)
1.35 (1.24, 1.47)
1.77 (1.53, 2.05)
1.55 (1.22, 1.98)
1.19 (0.99, 1.42)
2.29 (2.25, 2.33)
1.75 (1.48, 2.07)
1.80 (1.63, 2.00)
1.32 (1.22, 1.43)
1.60 (1.27, 2.01)
1.22 (1.12, 1.34)
1.60 (1.38, 1.86)
1.43 (1.12, 1.84)
1.14 (0.95, 1.37)
1.86 (1.83, 1.89)
1.65 (1.39, 1.95)
1.70 (1.53, 1.89)
1.23 (1.14, 1.33)
1.46 (1.23, 1.74)
HR (95% CI)
12.78
12.47
11.73
12.22
12.94
12.34
12.72
12.81
100.00
12.90
12.45
11.43
12.13
13.12
12.25
12.79
12.93
100.00
13.16
12.39
10.65
11.83
13.63
12.07
12.98
13.29
100.00
Weight
%
Lower risk  Higher risk of death 
1.8 1.2 1.8 2.4 2.8
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B) 
NOTE: Weights are from random effects analysis
.
.
.
Model 1
EPIC-Elderly
ESTHER
HAPIEE
MORGAM
NIH-AARP
SENECA
SHARE
TROMSO
Subtotal  (I-squared = 98.6%, p = 0.000)
Model 2
EPIC-Elderly
ESTHER
HAPIEE
MORGAM
NIH-AARP
SENECA
SHARE
TROMSO
Subtotal  (I-squared = 98.3%, p = 0.000)
Model 3
EPIC-Elderly
ESTHER
HAPIEE
MORGAM
NIH-AARP
SENECA
SHARE
TROMSO
Subtotal  (I-squared = 96.5%, p = 0.000)
study
CHANCES
12730
5514
15034
2844
360497
2015
19509
5587
12730
5514
15034
2844
360497
2015
19509
5587
12730
5514
15034
2844
360497
2015
19509
5587
N
2453
776
1860
1414
80168
791
2314
2967
2453
776
1860
1414
80168
791
2314
2967
2453
776
1860
1414
80168
791
2314
2967
Deaths
2.27 (2.00, 2.58)
3.00 (2.07, 4.36)
3.19 (2.48, 4.11)
3.22 (2.52, 4.13)
5.81 (5.64, 5.99)
2.88 (2.28, 3.62)
3.53 (3.15, 3.95)
1.97 (1.71, 2.27)
3.09 (2.11, 4.52)
2.18 (1.92, 2.48)
2.25 (1.54, 3.29)
2.72 (2.12, 3.49)
3.07 (2.39, 3.93)
4.90 (4.76, 5.05)
2.72 (2.15, 3.44)
3.07 (2.73, 3.45)
1.80 (1.56, 2.08)
2.73 (1.93, 3.87)
1.86 (1.63, 2.12)
1.99 (1.36, 2.92)
2.25 (1.73, 2.92)
2.59 (2.00, 3.34)
3.46 (3.35, 3.57)
2.41 (1.90, 3.07)
2.69 (2.38, 3.05)
1.62 (1.40, 1.87)
2.31 (1.79, 2.99)
HR (95% CI)
12.81
11.56
12.30
12.32
12.99
12.40
12.85
12.77
100.00
12.88
11.33
12.28
12.29
13.10
12.37
12.92
12.82
100.00
13.21
10.52
11.99
12.05
13.65
12.23
13.25
13.11
100.00
Weight
%
Lower risk  Higher risk of death 
1.8 2 3 4 6
 
 
Abbreviations: CI, Confidence Interval; EPIC, European Prospective Investigation into Cancer and nutrition; 
ESTHER, Epidemiological Study on Chances for Prevention. Early Detection. and Optimized THErapy of Chronic 
Diseases at Old Age; HAPIEE, the Health. Alcohol and Psychosocial factors in Eastern Europe; HR, Hazard Ratio; 
MORGAM, MOnica Risk. Genetics. Archiving and Monograph; NIH-AARP, National Institutes of Health-American 
Association of Retired Persons Diet and Health; SENECA, Survey Europe on Nutrition in the Elderly: a Concerted 
Action; SHARE, Survey of Health. Ageing and REtirement in Europe;  
 
Model 1: Stratified for age and adjusted for sex 
Model 2: As in Model 1 and additionally for: physical activity, smoking, ethanol intake, body mass index, 
education and marital status  
Model 3: As in Model 2 and additionally for: Prevalent cancer at recruitment (yes/no); Prevalent coronary heart 
disease at recruitment (yes/no); Prevalent stroke at recruitment (yes/no); Prevalent type 2 diabetes mellitus at 
recruitment (yes/no) 
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Annex 
Supplementary Table 1. Selected Characteristics of the Studies and Cohorts Included in the Current 
Investigation of the Consortium on Health and Ageing: Network of Cohorts in Europe and the United 
States Participants. 
No Study Cohorts included in the 
analysis 
Period of 
enrolment 
Period of 
follow-up 
Referencea Individual data 
analysed centrally 
1 EPIC-Elderly 
(selected centres) 
GR. NL. SE 1992-1999 1993-2011 Trichopoulou et al. 
2005 
Yes 
2 ESTHER DE 
 
2000-2002 2000-2010 
 
Schöttker et al. 2013 Yes 
3 HAPIEE CZ. PL. RU 
LT 
2002-2008 
 
2002-2010 
 
Peasey  et al. 2006 No 
4 MORGAMb DK. DE.  1982-2001 1983-2010 Evans et al. 2005 Yes 
5 NIH-AARP USA 
 
1995-1997 1995-2008 Schatzkin et al. 2001 Yes 
6 SENECA BE. DK. FR. IT.  NL.   ES. 
CH. GR. HU.  NO. PT. PL 
1988-1989 1993 - 1999 De Groot and van 
Staveren. 1991 
 
No 
7 SHAREc AT. BE. CH. CZ. DE. DK. 
ES. FR. GR. IL. IT. NL. 
PL. SE.  
2004-2007 2004 - 2012 Börsch-Supan et al. 
2013 
Yes 
8 The Tromsø study NO 1994-1995 1995-2010 Jacobsen et al. 2012 Yes 
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Abbreviations: EPIC: European Prospective Investigation into Cancer and nutrition; ESTHER: 
Epidemiological Study on Chances for Prevention. Early Detection. and Optimized THErapy of 
Chronic Diseases at Old Age; HAPIEE: the Health. Alcohol and Psychosocial factors in Eastern 
Europe; MORGAM: MOnica Risk. Genetics. Archiving and Monograph; NIH-AARP: National 
Institutes of Health-American Association of Retired Persons Diet and Health; SENECA: Survey 
Europe on Nutrition in the Elderly: a Concerted Action; SHARE: Survey of Health. Ageing and 
REtirement in Europe; Austria (AT); Belgium (BE); Czech Republic (CZ); Germany (DE); Hungary 
(HU); Sweden (SE); Switzerland (CH); Denmark (DK); Greece (GR); The Netherlands (NL); Spain 
(ES); France (FR); Italy (IT); Poland (PL); Portugal (PT); United States of America (USA); Lithuania 
(LT); Russia (RU);  Norway (NO); Israel (IL)  
a The indicated references are listed below  
b More cohorts are included in the MORGAM study 
(http://www.thl.fi/publications/morgam/cohorts/tables/base_summary.htm) but only those indicated in 
this Table participated in the current study  
c SHARE conducts end-of-life interviews for deceased respondents. These end-of-life interviews are 
administered to relatives or other persons close to the deceased. 
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Supplementary Table 2. Distribution of Participants (Column %) by Medical History and Categories of 
Self-Rated Health at Recruitment (1982-2008).  The Consortium on Health and Ageing: Network of 
Cohorts in Europe and the United States Participants. 
 Self-Rated Health 
STUDY “at-least-gooda” “Fair” “Poor” Total 
EPIC-Elderly (%)     
Prevalent Cancer 3.65 4.62 8.81 4.4 
Prevalent coronary heart disease 1.73 6.42 8.33 3.86 
Prevalent stroke 0.63 3.63 4.51 1.96 
Prevalent diabetes 7.16 16.88 17.24 11.29 
At least one of the above 12.49 28.01 33.4 19.47 
ESTHER (%)     
Prevalent Cancer 7.29 9.32 8.82 7.91 
Prevalent coronary heart disease 5.51 9.44 16.67 6.86 
Prevalent stroke 2.99 7.75 15.69 4.61 
Prevalent diabetes 14.27 24.89 29.41 17.63 
At least one of the above 26.07 41.28 50.98 30.94 
HAPIEE (%)     
Prevalent Cancer 4.31 8.04 10.05 6.43 
Prevalent coronary heart disease 5.15 10.39 17.98 10.69 
Prevalent stroke 1.92 4.28 12.45 5.30 
Prevalent diabetes 7.43 12.17 20.34 12.68 
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At least one of the above 17.11 27.96 46.60 29.07 
     
MORGAM (%)     
Prevalent Cancer1     
Prevalent coronary heart disease 5.15 9.59 17.54 6.36 
Prevalent stroke 2.86 6.32 13.16 3.83 
Prevalent diabetes 7.18 19.17 30.7 10.06 
At least one of the above 13.74 30.5 44.74 17.69 
NIH_-ARP (%)     
Prevalent Cancer 1.57 3.25 5.57 1.87 
Prevalent coronary heart disease 12.91 39.00 53.46 17.03 
Prevalent stroke 1.76 7.72 14.65 2.78 
Prevalent diabetes 7.57 24.85 33.62 10.28 
At least one of the above 21.14 57.12 70.77 26.70 
SENECA (%)     
Prevalent Cancer 1.68 2.36 2.35 1.96 
Prevalent coronary heart disease 10.92 21.78 26.67 15.96 
Prevalent stroke 1.60 3.05 7.45 2.68 
Prevalent diabetes 6.12 10.26 15.69 8.43 
At least one of the above 18.72 32.04 42.75 25.42 
SHARE (%)     
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Prevalent Cancer 4.76 7.02 10.73 6.23 
Prevalent coronary heart disease 9.31 24.14 36.96 17.44 
Prevalent stroke 2.25 6.50 15.93 5.35 
Prevalent diabetes 7.54 16.89 23.80 12.51 
At least one of the above 20.96 44.82 63.19 33.74 
TROMSØ (%)     
Prevalent Cancer 6.70 8.80 13.68 8.11 
Prevalent coronary heart disease 5.91 13.64 19.87 10.45 
Prevalent stroke 2.82 6.86 14.01 5.41 
At least one of the above 16.53 30.84 45.28 25.09 
EPIC: European Prospective Investigation into Cancer and nutrition; ESTHER: Epidemiological Study 
on Chances for Prevention. Early Detection. and Optimized THErapy of Chronic Diseases at Old Age; 
HAPIEE: the Health. Alcohol and Psychosocial factors in Eastern Europe; MORGAM: MOnica Risk. 
Genetics. Archiving and Monograph; NIH-AARP: National Institutes of Health-American Association 
of Retired Persons Diet and Health; SENECA: Survey Europe on Nutrition in the Elderly: a Concerted 
Action; SHARE: Survey of Health. Ageing and REtirement in Europe 
a No data available in MORGAM 
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Supplementary Table 3. Adjusteda HR and 95% CI of All-Cause Mortality Associated with Self-Rated 
Health, in Specific Subgroups.  The Consortium on Health and Ageing: Network of Cohorts in Europe 
and the United States Participants. 
Subgroups N Deaths HRfair/“at-least-
good” 
95% CI HRpoor/“at- 
least- good” 
95% CI 
    lower upper  lower Upper 
Morbidity scoreb         
0  309,921 53,875 1.50c 1.17 1.91 2.64c 1.72 4.03 
1 89,322 27,825 1.42d 1.22 1.65 2.11d 1.57 2.83 
>2   19,587 9,918 1.46e 1.40 1.53 2.41e 2.27 2.56 
Sex         
Males 249,204 62,052 1.44f 1.21 1.71 2.30f 1.79 2.95 
Females 174,526 30,691 1.50g 1.26 1.79 2.35g 1.77 3.11 
Recruitment age (years)h         
<70  369,964 78,483 1.58i 1.29 1.93 2.59i 2.03 3.32 
>70  38,732 12,380 1.39j 1.21 1.60 2.14j 1.64 2.79 
Educationk         
Up to primary  30,641 7,708 1.39l 1.21 1.59 2.04l 1.69 2.48 
>Primary to < college 112,957 27,147 1.40m 1.16 1.68 2.55m 1.99 3.27 
College or more 251,694 52,123 1.74n 1.41 2.15 3.38n 2.42 4.73 
Abbreviations: HR, Hazard Ratio; CI, Confidence Interval   
a Adjusted by Model 3.   
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 b Sum of indicators (1=yes, 0=no) for the following health conditions:  coronary heart disease, stroke, diabetes 
mellitus, cancer at recruitment. In subgroups with morbidity score 1 or >2 HAPPIEE and SENECA were not 
included due to non-available individual data.   
c I2 for heterogeneity: HRfair/”at-least-good” ,: 97.3%, HRpoor / “at-least-good” ,: 97.7% 
d I2 for heterogeneity: HRfair/”at-least-good” : 82.3%, HRpoor / “at-least-good”:  89.9% 
e I2 for heterogeneity: HRfair/”at-least-good”:<1%, HRpoor / “at-least-good” : <1%  
f I2 for heterogeneity: HRfair/”at-least-good”:94.1%, HRpoor / “at-least-good”: 92.6% 
g I2 for heterogeneity: HRfair/”at-least-good”: 92.2%, HRpoor / “at-least-good”: 93.2% 
h HAPPIEE was not included due to non-available individual data.  
i I2 for heterogeneity: HRfair/”at-least-good”:95.0%, HRpoor / “at-least-good”: 91.3% 
j I2 for heterogeneity: HRfair/”at-least-good”: 87.1%, HRpoor / “at-least-good”: 91.7%  
k HAPPIEE and SENECA were not included due to non-available individual data 
l I2 for heterogeneity: HRfair/”at-least-good”: 82.3%, HRpoor / “at-least-good”: 80.4% 
m I2 for heterogeneity: HRfair/”at-least-good”: 86.4%, HRpoor / “at-least-good”: 78.5% 
n I2 for heterogeneity: HRfair/”at-least-good”: 57.2%, HRpoor / “at-least-good”: 47.7% 
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Supplementary Table 4. ORa of Self-Rated Health as “at- least-good” rather Than “fair or poor” 
Associated with Characteristics at Enrolment.  The Consortium on Health and Ageing: Network of 
Cohorts in Europe and the United States Participants. 
Characteristics at recruitment OR 95% CI Ibfor heterogeneity 
 
 
Lower Upper 
 
Sex (Reference: Female)     
 Males 1.20 1.05 1.37 91% 
Age     
Per year increment 0.98 0.97 0.99 85.1% 
Body Mass Index  
(Reference: <25  kg/m2):   
  
 
 
(>25 – <30) kg/m2   1.01 0.98 1.03 <1% 
> 30 kg/m2   0.75 0.65 0.86 86.6% 
Smoking  
(Reference: no smoking) 
  
 
 
Daily  0.92 0.76 1.12 93.9% 
Ethanol intake2  
(Reference: 1st tertile) 
  
 
 
2nd tertile 1.40 1.28 1.54 81.7% 
3rd tertile 1.53 1.38 1.69 76.4% 
Marital Status  
(Reference: married/cohabiting) 
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single/separated  0.86 0.76 0.97 59.7% 
widowed  0.92 0.84 1.00 71.3% 
Education 
 (Reference: <primary) 
  
 
 
 >primary - <college  1.47 1.19 1.82 92.9% 
>college  1.96 1.44 2.65 93.1% 
Health conditions at recruitmentc  
(Reference: none) 
  
 
 
At least one  0.44 0.34 0.57 98.5% 
Physical Activityd:  
(Reference: Inactive) 
  
 
 
Active4 1.88 1.53 2.31 96.0% 
Abbreviations: OR, Odds Ratio 
a Estimated from meta-analysis of mutually adjusted ORs, derived from multivariate logistic regressions 
undertaken in each of the participating studies, 
b Tertiles estimated from sex and study specific ethanol intake at enrolment, 
c Health conditions considered at recruitment: cancer, coronary heart disease, stroke, diabetes mellitus 
d Active: >0 hours of vigorous physical activity/week, Inactive: 0 hours of vigorous physical activity/week. 
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